Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -41.82x is 36% below its 2-year average of -30.84x, near the low end of its 2-year range (-45.84x–-13.58x).
As of the fiscal period ended Friday, March 31, 2017. 12.50% below its 12-month average of -37.17x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2017 (2017-03-31): -41.82x.
INTEREST COVERAGE RATIO
-41.82x
INTEREST COVERAGE RATIO AVG TTM
-37.17x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-12.50%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 450 covered companies
CURRENT VS SECTOR MEDIAN
-654.79%
vs the sector median at left
CytomX Therapeutics, Inc.
Market Cap
$569.16M
Interest Coverage Ratio
-41.82x
TTM Avg
-37.17x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$566.81M
Interest Coverage Ratio
53.97x
TTM Avg
53.97x
3Y Avg
53.97x
5Y Avg
53.97x
Market Cap
$573.38M
Interest Coverage Ratio
-4.07x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$560.00M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$554.29M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$554.88M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$554.42M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$587.06M
Interest Coverage Ratio
-4.84x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$593.86M
Interest Coverage Ratio
-1214.61x
TTM Avg
176.24x
3Y Avg
176.24x
5Y Avg
176.24x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | $569.16M | -41.82x | -37.17x | N/A | N/A |
| CorMedix Inc. (CRMD)vs › | $566.81M | 53.97x | 53.97x | 53.97x | 53.97x |
| Aquestive Therapeutics, Inc. (AQST)vs › | $573.38M | -4.07x | N/A | N/A | N/A |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $554.29M | N/A | N/A | N/A | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $554.88M | N/A | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $554.42M | N/A | N/A | N/A | N/A |
| OrthoPediatrics Corp. (KIDS)vs › | $587.06M | -4.84x | N/A | N/A | N/A |
| Fulgent Genetics, Inc. (FLGT)vs › | $593.86M | -1214.61x | 176.24x | 176.24x | 176.24x |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $542.04M | -2.35x | N/A | N/A | N/A |
Interest Coverage
-41.8x
Debt/Equity
0.02
Current Ratio
9.36
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2017-03-31 | -41.82x |
| 2016-12-31 | -36.58x |
| 2016-09-30 | -30.95x |
| 2016-06-30 | -30.66x |
| 2016-03-31 | -45.84x |
| 2015-12-31 | -30.65x |
| 2015-09-30 | -15.69x |
| 2015-06-30 | -13.58x |
| 2015-03-31 | -21.17x |
| 2014-12-31 | -42.74x |
| 2014-09-30 | -29.61x |
